Previous Close | 481.10 |
Open | 484.00 |
Bid | 0.00 x 0 |
Ask | 0.00 x 0 |
Day's Range | 478.70 - 487.40 |
52 Week Range | 308.60 - 559.40 |
Volume | |
Avg. Volume | 204,327 |
Market Cap | 34.638B |
Beta (5Y Monthly) | 0.63 |
PE Ratio (TTM) | 54.03 |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | 4.00 (0.83%) |
Ex-Dividend Date | May 13, 2024 |
1y Target Est | N/A |
Explore key insights from Acumen Pharmaceuticals' Q1 2024 earnings, focusing on their innovative Alzheimer's treatments and financial outlook.
Despite a net loss, MRVI showcases strategic expansions and robust partnerships, setting the stage for future growth.
Lonza Group ( VTX:LONN ) Full Year 2023 Results Key Financial Results Revenue: CHF6.72b (up 7.9% from FY 2022). Net...